| Total (n = 65) | Infl group (n = 44) | Etan group (n = 21) | ||||
| Baseline | 12 months | Baseline | 12 months | Baseline | 12 months | |
| T Chol, mg/dl | 180 (35.2) | 197.7 (35.3)* | 181.9 (38.2) | 203.6 (36.6)§ | 177.3 (27.2) | 184.8 (29.4) |
| HDL, mg/dl | 57.3 (20.1) | 59.8 (17.8) | 60.7 (22.9) | 60.7 (19.1) | 51.1 (12.7) | 58.2 (16.2)†† |
| LDL, mg/dl | 104.8 (36.2) | 122.6 (32.8)† | 102.4 (35.7) | 128.5 (32.6)¶ | 109.6 (39.4) | 110 (39.3) |
| TG, mg/dl | 101.6 (45.2) | 111.9 (64.7) | 110.1 (48.3) | 125.6 (70.9) | 84.1 (31.9) | 80.1 (31.7) |
| T Chol/HDL | 3.4 (1.0) | 3.5 (1.0) | 3.3 (1.1) | 3.6 (1.0) | 3.6 (1.1) | 3.5 (1.1) |
| LDL/HDL | 1.9 (0.9) | 2.2 (0.8)‡ | 1.8 (0.86) | 2.3 (0.7)** | 2.1 (0.9) | 2.1 (1.1) |
Baseline versus 12 months (Student t test): *p<0.0001; †p = 0.02; ‡p = 0.005; §p<0.001; ¶p = 0.003; **p = 0.01; ††p<0.05.
T Chol, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides; Infl, infliximab; Etan, etanercept.